| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | $5.8B | $5.5B | $5.9B | $4.5B |
| Cost of Revenue | $3.4B | $3.2B | $2.9B | $2.4B |
| Gross Profit | $2.4B | $2.3B | $3.0B | $2.1B |
| R&D Expense | $2.0B | $1.9B | $1.8B | $1.4B |
| SG&A Expense | $0.8B | $0.8B | — | — |
| Operating Income | $-0.7B | $-0.6B | $0.2B | $-0.3B |
| Net Income | $-0.9B | $-0.9B | $-0.2B | $-0.4B |
| EPS (Basic) | $-1.02 | $-1.08 | $-0.19 | $-0.53 |
| EPS (Diluted) | $-1.02 | $-1.08 | $-0.19 | $-0.53 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $20.2B | $21.2B | $22.5B | $22.1B |
| Current Assets | $3.1B | $3.1B | $3.3B | $2.5B |
| Cash & Equivalents | $0.9B | $1.0B | $0.9B | $0.6B |
| Total Liabilities | $6.8B | $6.4B | $6.9B | $6.4B |
| Current Liabilities | $2.0B | $1.8B | $2.4B | $1.4B |
| Stockholders' Equity | $13.4B | $14.8B | $15.6B | $15.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $1.4B | $1.3B | $0.8B |
| Investing Cash Flow | $-0.3B | $-0.4B | $-0.3B | $-3.7B |
| Capital Expenditures | $0.3B | $0.3B | $0.2B | $0.2B |
| Financing Cash Flow | $-1.4B | $-1.0B | $-0.7B | $2.8B |